Kim, Hanseul
Nelson, Paul
Nzabarushimana, Etienne
Shen, Jiaxian https://orcid.org/0000-0003-4929-8955
Jensen, Jordan
Bhosle, Amrisha
Li, Chengchen
Lee, Nawon
Everett, Christine
Berdy, Brittany https://orcid.org/0000-0002-8593-0762
Frongillo, Giana
Livny, Jonathan
Hu, Frank B. https://orcid.org/0000-0002-8233-6274
Simon, Tracey G.
McIver, Lauren
Franzosa, Eric A.
Chan, Andrew T. https://orcid.org/0000-0001-7284-6767
Hayete, Boris
Thompson, Kelsey N.
Huttenhower, Curtis https://orcid.org/0000-0002-1110-0096
Nguyen, Long H. https://orcid.org/0000-0002-5436-4219
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (K23DK125838, T32CA009001, R35CA253185, R24DK110499)
American Gastroenterological Association (Research Scholars Award)
Crohn's and Colitis Foundation (Career Development Award)
Massachusetts General Hospital/Chen Institute Transformative Scholar in Medicine
American Cancer Society (Research Professorship)
Article History
Received: 14 August 2024
Accepted: 14 May 2025
First Online: 2 July 2025
Competing interests
: P.N. and B.H. were employees of Empress Therapeutics. C.H. is on the Scientific Advisory Board of Empress Therapeutics, Seres Therapeutics and ZOE Nutrition. All others declare no competing interests.